{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T21:59:41Z","timestamp":1791928781535,"version":"4.3.4"},"reference-count":36,"publisher":"Association for Research in Vision and Ophthalmology (ARVO)","issue":"6","license":[{"start":{"date-parts":[[2021,5,3]],"date-time":"2021-05-03T00:00:00Z","timestamp":1620000000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Invest. Ophthalmol. Vis. Sci."],"published-print":{"date-parts":[[2021,5,3]]},"DOI":"10.1167\/iovs.62.6.2","type":"journal-article","created":{"date-parts":[[2021,5,3]],"date-time":"2021-05-03T08:49:15Z","timestamp":1620031755000},"page":"2","source":"Crossref","is-referenced-by-count":17,"title":["Expanding the\n                    <i>FDXR<\/i>\n                    -Associated Disease Phenotype: Retinal Dystrophy Is a Recurrent Ocular Feature"],"prefix":"10.1167","volume":"62","author":[{"given":"Neringa","family":"Jurkute","sequence":"first","affiliation":[{"name":"Moorfields Eye Hospital NHS Foundation Trust, London, United Kingdom"},{"name":"Institute of Ophthalmology, University College London, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priya D.","family":"Shanmugarajah","sequence":"additional","affiliation":[{"name":"Academic Department of Neurosciences, Royal Hallamshire Hospital, Sheffield, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marios","family":"Hadjivassiliou","sequence":"additional","affiliation":[{"name":"Academic Department of Neurosciences, Royal Hallamshire Hospital, Sheffield, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenny","family":"Higgs","sequence":"additional","affiliation":[{"name":"Liverpool Centre for Genomic Medicine, Liverpool Women's Hospital, Liverpool, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miodrag","family":"Vojcic","sequence":"additional","affiliation":[{"name":"Departments of Neurology and Ophthalmology, Royal Victoria Infirmary, Newcastle upon Tyne, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iain","family":"Horrocks","sequence":"additional","affiliation":[{"name":"Paediatric Neurosciences Research Group, Royal Hospital for Children, Glasgow, Scotland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yann","family":"Nadjar","sequence":"additional","affiliation":[{"name":"Department of Neurology, Reference Center for Lysosomal Diseases, Neuro-Genetic and Metabolism Unit, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valerie","family":"Touitou","sequence":"additional","affiliation":[{"name":"Sorbonne University, Paris, France"},{"name":"Groupe Hospitalier La Piti\u00e9 Salp\u00eatri\u00e8re-Charles Foix, DHU Vision Et Handicaps, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guy","family":"Lenaers","sequence":"additional","affiliation":[{"name":"Universit\u00e9 Angers, MitoLab team, UMR CNRS 6015 - INSERM U1083, Angers, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roy","family":"Poh","sequence":"additional","affiliation":[{"name":"Department of Neurogenetics, The National Hospital for Neurology and Neurosurgery and UCL Institute of Neurology, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Acheson","sequence":"additional","affiliation":[{"name":"Moorfields Eye Hospital NHS Foundation Trust, London, United Kingdom"},{"name":"National Hospital for Neurology and Neurosurgery, University College London Hospitals NHS trust, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony G.","family":"Robson","sequence":"additional","affiliation":[{"name":"Moorfields Eye Hospital NHS Foundation Trust, London, United Kingdom"},{"name":"Institute of Ophthalmology, University College London, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F. Lucy","family":"Raymond","sequence":"additional","affiliation":[{"name":"NIHR BioResource - Rare Diseases, Cambridge University Hospitals NHS Foundation Trust, Cambridge Biomedical Campus, Cambridge, United Kingdom"},{"name":"Department of Medical Genetics, Cambridge Institute for Medical Research, University of Cambridge, Cambridge, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary M.","family":"Reilly","sequence":"additional","affiliation":[{"name":"Centre for Neuromuscular Diseases, UCL Queen Square Institute of Neurology and National Hospital for Neurology and Neurosurgery, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Yu-Wai-Man","sequence":"additional","affiliation":[{"name":"Moorfields Eye Hospital NHS Foundation Trust, London, United Kingdom"},{"name":"Institute of Ophthalmology, University College London, London, United Kingdom"},{"name":"Cambridge Eye Unit, Addenbrooke's Hospital, Cambridge University Hospitals, Cambridge, United Kingdom"},{"name":"John van Geest Centre for Brain Repair and MRC Mitochondrial Biology Unit, Department of Clinical Neurosciences, University of Cambridge, Cambridge, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony T.","family":"Moore","sequence":"additional","affiliation":[{"name":"Moorfields Eye Hospital NHS Foundation Trust, London, United Kingdom"},{"name":"Institute of Ophthalmology, University College London, London, United Kingdom"},{"name":"Department of Ophthalmology, University of California, San Francisco, San Francisco, California, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew R.","family":"Webster","sequence":"additional","affiliation":[{"name":"Moorfields Eye Hospital NHS Foundation Trust, London, United Kingdom"},{"name":"Institute of Ophthalmology, University College London, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gavin","family":"Arno","sequence":"additional","affiliation":[{"name":"Moorfields Eye Hospital NHS Foundation Trust, London, United Kingdom"},{"name":"Institute of Ophthalmology, University College London, London, United Kingdom"},{"name":"Great Ormond Street Hospital for Children, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"for the Genomics England Research Consortium","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"27","reference":[{"issue":"24","key":"bib1","doi-asserted-by":"publisher","first-page":"4937","DOI":"10.1093\/hmg\/ddx377","article-title":"Biallelic mutations in the ferredoxin reductase gene cause novel mitochondriopathy with optic atrophy","volume":"26","author":"Peng","year":"2017","journal-title":"Hum Mol Genet"},{"issue":"4","key":"bib2","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1016\/j.ajhg.2017.09.007","article-title":"FDXR mutations cause sensorial neuropathies and expand the spectrum of mitochondrial Fe-S-synthesis diseases","volume":"101","author":"Paul","year":"2017","journal-title":"Am J Hum Genet"},{"issue":"3","key":"bib3","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1002\/humu.v42.3","article-title":"Expanding the clinical and genetic spectrum of FDXR deficiency by functional validation of variants of uncertain significance","volume":"42","author":"Stenton","year":"2021","journal-title":"Hum Mutat"},{"issue":"12","key":"bib4","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1038\/s10038-018-0515-y","article-title":"Biallelic mutations in FDXR cause neurodegeneration associated with inflammation","volume":"63","author":"Slone","year":"2019","journal-title":"J Hum Genet"},{"issue":"25","key":"bib5","doi-asserted-by":"publisher","first-page":"2478","DOI":"10.1056\/NEJMc1812033","article-title":"Reanalysis of clinical exome sequencing data","volume":"380","author":"Liu","year":"2019","journal-title":"N Engl J Med"},{"issue":"2","key":"bib6","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1242\/dmm.009019","article-title":"Biogenesis of iron-sulfur clusters in mammalian cells: new insights and relevance to human disease","volume":"5","author":"Rouault","year":"2012","journal-title":"Dis Model Mech"},{"issue":"1","key":"bib7","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1039\/C7MT00180K","article-title":"Iron-sulfur cluster biosynthesis and trafficking - impact on human disease conditions","volume":"10","author":"Wachnowsky","year":"2018","journal-title":"Metallomics"},{"issue":"1","key":"bib8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10633-012-9353-y","article-title":"ISCEV standard for clinical pattern electroretinography (PERG): 2012 update","volume":"126","author":"Bach","year":"2013","journal-title":"Doc Ophthalmol"},{"issue":"1","key":"bib9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10633-014-9473-7","article-title":"ISCEV Standard for full-field clinical electroretinography (2015 update)","volume":"130","author":"McCulloch","year":"2015","journal-title":"Doc Ophthalmol"},{"issue":"1","key":"bib11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10633-016-9553-y","article-title":"ISCEV standard for clinical visual evoked potentials: (2016 update)","volume":"133","author":"Odom","year":"2016","journal-title":"Doc Ophthalmol"},{"issue":"1","key":"bib12","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.ajhg.2016.12.003","article-title":"Comprehensive rare variant analysis via whole-genome sequencing to determine the molecular pathology of inherited retinal disease","volume":"100","author":"Carss","year":"2017","journal-title":"Am J Hum Genet"},{"issue":"4","key":"bib13","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1001\/jamaophthalmol.2017.0046","article-title":"Association of steroid 5a-reductase type 3 congenital disorder of glycosylation with early-onset retinal dystrophy","volume":"135","author":"Taylor","year":"2017","journal-title":"JAMA Ophthalmol"},{"issue":"11","key":"bib14","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1038\/s41588-019-0528-2","article-title":"PanelApp crowdsources expert knowledge to establish consensus diagnostic gene panels","volume":"51","author":"Martin","year":"2019","journal-title":"Nat Genet"},{"issue":"2","key":"bib15","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1093\/bib\/bbs017","article-title":"Integrative genomics viewer (IGV): high-performance genomics data visualization and exploration","volume":"14","author":"Thorvaldsd\u00f3ttir","year":"2013","journal-title":"Brief Bioinform"},{"issue":"5","key":"bib16","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"},{"issue":"1","key":"bib17","first-page":"108","article-title":"SSBP1 mutations cause mtDNA depletion underlying a complex optic atrophy disorder","volume":"130","author":"Del","year":"2020","journal-title":"J Clin Invest"},{"issue":"1","key":"bib18","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1172\/JCI128513","article-title":"Dominant mutations in mtDNA maintenance gene SSBP1 cause optic atrophy and foveopathy","volume":"130","author":"Piro-m\u00e9gy","year":"2020","journal-title":"J Clin Invest"},{"issue":"3","key":"bib19","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1002\/ana.v86.3","article-title":"SSBP1 mutations in dominant optic atrophy with variable retinal degeneration","volume":"86","author":"Jurkute","year":"2019","journal-title":"Ann Neurol"},{"issue":"3","key":"bib20","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/j.ajhg.2012.01.009","article-title":"Infantile cerebellar-retinal degeneration associated with a mutation in mitochondrial aconitase, ACO2","volume":"90","author":"Spiegel","year":"2012","journal-title":"Am J Hum Genet"},{"issue":"12","key":"bib21","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1167\/iovs.61.12.12","article-title":"Retinal manifestations of mitochondrial oxidative phosphorylation disorders","volume":"61","author":"Oh","year":"2020","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"bib22","article-title":"Combined optic atrophy and rod\u2013cone dystrophy expands the RTN4IP1 (optic atrophy 10) phenotype [published online ahead of print October 27, 2020]","author":"Rajabian","journal-title":"J Neuroophthalmol"},{"issue":"2","key":"bib23","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/j.bbamcr.2011.11.002","article-title":"Both human ferredoxins 1 and 2 and ferredoxin reductase are important for iron-sulfur cluster biogenesis","volume":"1823","author":"Shi","year":"2012","journal-title":"Biochim Biophys Acta"},{"issue":"6","key":"bib24","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1038\/s41419-020-2637-3","article-title":"Integrated analysis of the molecular pathogenesis of FDXR-associated disease","volume":"11","author":"Slone","year":"2020","journal-title":"Cell Death Dis"},{"issue":"11","key":"bib25","doi-asserted-by":"publisher","first-page":"3362","DOI":"10.3390\/ijms19113362","article-title":"Reactive oxygen species-mediated damage of retinal neurons: drug development targets for therapies of chronic neurodegeneration of the retina","volume":"19","author":"Rohowetz","year":"2018","journal-title":"Int J Mol Sci"},{"issue":"1","key":"bib26","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1159\/000027251","article-title":"Retinal degeneration in hereditary ceruloplasmin deficiency","volume":"212","author":"Yamaguchi","year":"1998","journal-title":"Ophthalmologica"},{"issue":"6","key":"bib27","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1016\/j.ophtha.2004.12.029","article-title":"Macular degeneration in a patient with aceruloplasminemia, a disease associated with retinal iron overload","volume":"112","author":"Dunaief","year":"2005","journal-title":"Ophthalmology"},{"issue":"2","key":"bib28","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1001\/archopht.125.2.273","article-title":"Catastrophic visual loss in a patient with Friedreich ataxia","volume":"125","author":"Porter","year":"2007","journal-title":"Arch Ophthalmol"},{"issue":"8","key":"bib29","doi-asserted-by":"publisher","first-page":"2289","DOI":"10.1093\/brain\/awy172","article-title":"A novel complex neurological phenotype due to a homozygous mutation in FDX2","volume":"141","author":"Gurgel-Giannetti","year":"2018","journal-title":"Brain"},{"issue":"7","key":"bib30","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1038\/ejhg.2013.269","article-title":"Deleterious mutation in FDX1L gene is associated with a novel mitochondrial muscle myopathy","volume":"22","author":"Spiegel","year":"2014","journal-title":"Eur J Hum Genet"},{"issue":"18","key":"bib31","doi-asserted-by":"publisher","first-page":"e100811","DOI":"10.15252\/embj.2018100811","article-title":"A single-cell transcriptome atlas of the adult human retina","volume":"38","author":"Lukowski","year":"2019","journal-title":"EMBO J"},{"issue":"7","key":"bib32","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/j.bbagen.2008.11.001","article-title":"Iron homeostasis and eye disease","volume":"1790","author":"Loh","year":"2009","journal-title":"Biochim Biophys Acta"},{"issue":"6","key":"bib33","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.preteyeres.2007.07.004","article-title":"Iron homeostasis and toxicity in retinal degeneration","volume":"26","author":"He","year":"2007","journal-title":"Prog Retin Eye Res"},{"issue":"12","key":"bib34","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1080\/14737175.2020.1821654","article-title":"Emerging therapies in Friedreich's ataxia","volume":"20","author":"Zesiewicz","year":"2020","journal-title":"Expert Rev Neurother"},{"issue":"4","key":"bib35","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1097\/WNO.0000000000000570","article-title":"International consensus statement on the clinical and therapeutic management of leber hereditary optic neuropathy","volume":"37","author":"Carelli","year":"2017","journal-title":"J Neuroophthalmol"},{"issue":"4","key":"bib36","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1136\/bjo.2005.082487","article-title":"Functional characterisation and serial imaging of abnormal fundus autofluorescence in patients with retinitis pigmentosa and normal visual acuity","volume":"90","author":"Robson","year":"2006","journal-title":"Br J Ophthalmol"},{"key":"bib10","first-page":"133","article-title":"Paediatric electrophysiology: a practical approach","volume-title":"Essentials in Ophthalmology","author":"Holder","year":"2006"}],"container-title":["Investigative Opthalmology &amp; Visual Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/iovs.arvojournals.org\/article.aspx?articleid=2772552","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T21:31:25Z","timestamp":1791927085000},"score":1,"resource":{"primary":{"URL":"https:\/\/iovs.arvojournals.org\/article.aspx?articleid=2772552"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,3]]},"references-count":36,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,5,3]]}},"URL":"https:\/\/doi.org\/10.1167\/iovs.62.6.2","relation":{},"ISSN":["1552-5783"],"issn-type":[{"value":"1552-5783","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5,3]]}}}